You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Sumatriptan plus naproxen for acute migraine attacks in adults
John Wiley & Sons, Ltd, October 2013
Law, Simon, Derry, Sheena, Moore, R Andrew
Migraine is a common disabling condition and a burden for the individual, health services, and society. Effective abortive treatments include the triptan and non-steroidal anti-inflammatory classes of drugs. These drugs have different mechanisms of action and combining them may provide better relief. Sumatriptan plus naproxen is now available in combination form for the acute treatment of migraine.
The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||15||63%|
|Practitioners (doctors, other healthcare professionals)||6||25%|
|Science communicators (journalists, bloggers, editors)||1||4%|
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||12||16%|
|Student > Bachelor||10||13%|
|Student > Master||9||12%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||33||44%|
|Nursing and Health Professions||3||4%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||4%|